NCT00293904View on ClinicalTrials.gov

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

February 28, 2007

Conditions
Hypersensitivity
Interventions
BIOLOGICAL

CYT005-AllQbG10

Trial Locations (1)

8091

University Hospital of Zürich, Zurich

Sponsors
All Listed Sponsors
lead

Cytos Biotechnology AG

INDUSTRY